Report cover image

Global Swine Live Vaccine Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 106 Pages
SKU # APRC20354791

Description

Summary

According to APO Research, The global Swine Live Vaccine market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Swine Live Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Swine Live Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Swine Live Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Swine Live Vaccine include Boehringer Ingelheim, Ceva Corporate, KM Biologics, Nisseiken, DHN, Harbin Pharmaceutical Group Bio-vaccine, Jinyu Biotechnology, Qindao Lijian Bio-Tech and Shenzhen BIOCBD Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Swine Live Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Live Vaccine.

The Swine Live Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Swine Live Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Swine Live Vaccine Segment by Company

Boehringer Ingelheim
Ceva Corporate
KM Biologics
Nisseiken
DHN
Harbin Pharmaceutical Group Bio-vaccine
Jinyu Biotechnology
Qindao Lijian Bio-Tech
Shenzhen BIOCBD Biotechnology
Wuhan Keqian Biology
Zhongmu Industry

Swine Live Vaccine Segment by Type

Swine Fever Vaccine
Porcine Reproductive and Respiratory Syndrome Vaccine
Pseudorabies Vaccine
Others

Swine Live Vaccine Segment by Application

Breeding Farm
Veterinary Clinic

Swine Live Vaccine Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Live Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Swine Live Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Live Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Swine Live Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Swine Live Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Table of Contents

106 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Swine Live Vaccine Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Swine Live Vaccine Sales Estimates and Forecasts (2020-2031)
1.3 Swine Live Vaccine Market by Type
1.3.1 Swine Fever Vaccine
1.3.2 Porcine Reproductive and Respiratory Syndrome Vaccine
1.3.3 Pseudorabies Vaccine
1.3.4 Others
1.4 Global Swine Live Vaccine Market Size by Type
1.4.1 Global Swine Live Vaccine Market Size Overview by Type (2020-2031)
1.4.2 Global Swine Live Vaccine Historic Market Size Review by Type (2020-2025)
1.4.3 Global Swine Live Vaccine Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Swine Live Vaccine Sales Breakdown by Type (2020-2025)
1.5.2 Europe Swine Live Vaccine Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Swine Live Vaccine Sales Breakdown by Type (2020-2025)
1.5.4 South America Swine Live Vaccine Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Swine Live Vaccine Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Swine Live Vaccine Industry Trends
2.2 Swine Live Vaccine Industry Drivers
2.3 Swine Live Vaccine Industry Opportunities and Challenges
2.4 Swine Live Vaccine Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Swine Live Vaccine Revenue (2020-2025)
3.2 Global Top Players by Swine Live Vaccine Sales (2020-2025)
3.3 Global Top Players by Swine Live Vaccine Price (2020-2025)
3.4 Global Swine Live Vaccine Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Swine Live Vaccine Major Company Production Sites & Headquarters
3.6 Global Swine Live Vaccine Company, Product Type & Application
3.7 Global Swine Live Vaccine Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Swine Live Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Swine Live Vaccine Players Market Share by Revenue in 2024
3.8.3 2023 Swine Live Vaccine Tier 1, Tier 2, and Tier 3
4 Swine Live Vaccine Regional Status and Outlook
4.1 Global Swine Live Vaccine Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Swine Live Vaccine Historic Market Size by Region
4.2.1 Global Swine Live Vaccine Sales in Volume by Region (2020-2025)
4.2.2 Global Swine Live Vaccine Sales in Value by Region (2020-2025)
4.2.3 Global Swine Live Vaccine Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Swine Live Vaccine Forecasted Market Size by Region
4.3.1 Global Swine Live Vaccine Sales in Volume by Region (2026-2031)
4.3.2 Global Swine Live Vaccine Sales in Value by Region (2026-2031)
4.3.3 Global Swine Live Vaccine Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Swine Live Vaccine by Application
5.1 Swine Live Vaccine Market by Application
5.1.1 Breeding Farm
5.1.2 Veterinary Clinic
5.2 Global Swine Live Vaccine Market Size by Application
5.2.1 Global Swine Live Vaccine Market Size Overview by Application (2020-2031)
5.2.2 Global Swine Live Vaccine Historic Market Size Review by Application (2020-2025)
5.2.3 Global Swine Live Vaccine Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Swine Live Vaccine Sales Breakdown by Application (2020-2025)
5.3.2 Europe Swine Live Vaccine Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Swine Live Vaccine Sales Breakdown by Application (2020-2025)
5.3.4 South America Swine Live Vaccine Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Swine Live Vaccine Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Comapny Information
6.1.2 Boehringer Ingelheim Business Overview
6.1.3 Boehringer Ingelheim Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer Ingelheim Swine Live Vaccine Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments
6.2 Ceva Corporate
6.2.1 Ceva Corporate Comapny Information
6.2.2 Ceva Corporate Business Overview
6.2.3 Ceva Corporate Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ceva Corporate Swine Live Vaccine Product Portfolio
6.2.5 Ceva Corporate Recent Developments
6.3 KM Biologics
6.3.1 KM Biologics Comapny Information
6.3.2 KM Biologics Business Overview
6.3.3 KM Biologics Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 KM Biologics Swine Live Vaccine Product Portfolio
6.3.5 KM Biologics Recent Developments
6.4 Nisseiken
6.4.1 Nisseiken Comapny Information
6.4.2 Nisseiken Business Overview
6.4.3 Nisseiken Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Nisseiken Swine Live Vaccine Product Portfolio
6.4.5 Nisseiken Recent Developments
6.5 DHN
6.5.1 DHN Comapny Information
6.5.2 DHN Business Overview
6.5.3 DHN Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 DHN Swine Live Vaccine Product Portfolio
6.5.5 DHN Recent Developments
6.6 Harbin Pharmaceutical Group Bio-vaccine
6.6.1 Harbin Pharmaceutical Group Bio-vaccine Comapny Information
6.6.2 Harbin Pharmaceutical Group Bio-vaccine Business Overview
6.6.3 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product Portfolio
6.6.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments
6.7 Jinyu Biotechnology
6.7.1 Jinyu Biotechnology Comapny Information
6.7.2 Jinyu Biotechnology Business Overview
6.7.3 Jinyu Biotechnology Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jinyu Biotechnology Swine Live Vaccine Product Portfolio
6.7.5 Jinyu Biotechnology Recent Developments
6.8 Qindao Lijian Bio-Tech
6.8.1 Qindao Lijian Bio-Tech Comapny Information
6.8.2 Qindao Lijian Bio-Tech Business Overview
6.8.3 Qindao Lijian Bio-Tech Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Qindao Lijian Bio-Tech Swine Live Vaccine Product Portfolio
6.8.5 Qindao Lijian Bio-Tech Recent Developments
6.9 Shenzhen BIOCBD Biotechnology
6.9.1 Shenzhen BIOCBD Biotechnology Comapny Information
6.9.2 Shenzhen BIOCBD Biotechnology Business Overview
6.9.3 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product Portfolio
6.9.5 Shenzhen BIOCBD Biotechnology Recent Developments
6.10 Wuhan Keqian Biology
6.10.1 Wuhan Keqian Biology Comapny Information
6.10.2 Wuhan Keqian Biology Business Overview
6.10.3 Wuhan Keqian Biology Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Wuhan Keqian Biology Swine Live Vaccine Product Portfolio
6.10.5 Wuhan Keqian Biology Recent Developments
6.11 Zhongmu Industry
6.11.1 Zhongmu Industry Comapny Information
6.11.2 Zhongmu Industry Business Overview
6.11.3 Zhongmu Industry Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Zhongmu Industry Swine Live Vaccine Product Portfolio
6.11.5 Zhongmu Industry Recent Developments
7 North America by Country
7.1 North America Swine Live Vaccine Sales by Country
7.1.1 North America Swine Live Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Swine Live Vaccine Sales by Country (2020-2025)
7.1.3 North America Swine Live Vaccine Sales Forecast by Country (2026-2031)
7.2 North America Swine Live Vaccine Market Size by Country
7.2.1 North America Swine Live Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Swine Live Vaccine Market Size by Country (2020-2025)
7.2.3 North America Swine Live Vaccine Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Swine Live Vaccine Sales by Country
8.1.1 Europe Swine Live Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Swine Live Vaccine Sales by Country (2020-2025)
8.1.3 Europe Swine Live Vaccine Sales Forecast by Country (2026-2031)
8.2 Europe Swine Live Vaccine Market Size by Country
8.2.1 Europe Swine Live Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Swine Live Vaccine Market Size by Country (2020-2025)
8.2.3 Europe Swine Live Vaccine Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Swine Live Vaccine Sales by Country
9.1.1 Asia-Pacific Swine Live Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Swine Live Vaccine Sales by Country (2020-2025)
9.1.3 Asia-Pacific Swine Live Vaccine Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Swine Live Vaccine Market Size by Country
9.2.1 Asia-Pacific Swine Live Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Swine Live Vaccine Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Swine Live Vaccine Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Swine Live Vaccine Sales by Country
10.1.1 South America Swine Live Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Swine Live Vaccine Sales by Country (2020-2025)
10.1.3 South America Swine Live Vaccine Sales Forecast by Country (2026-2031)
10.2 South America Swine Live Vaccine Market Size by Country
10.2.1 South America Swine Live Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Swine Live Vaccine Market Size by Country (2020-2025)
10.2.3 South America Swine Live Vaccine Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Swine Live Vaccine Sales by Country
11.1.1 Middle East and Africa Swine Live Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Swine Live Vaccine Sales by Country (2020-2025)
11.1.3 Middle East and Africa Swine Live Vaccine Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Swine Live Vaccine Market Size by Country
11.2.1 Middle East and Africa Swine Live Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Swine Live Vaccine Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Swine Live Vaccine Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Swine Live Vaccine Value Chain Analysis
12.1.1 Swine Live Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Swine Live Vaccine Production Mode & Process
12.2 Swine Live Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Swine Live Vaccine Distributors
12.2.3 Swine Live Vaccine Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.